• English
  • Eesti

    Estonian medicinal products market in the third quarter of 2014

    Printer-friendly version

    In the third quarter of 2014 the human and veterinary medicinal products market in wholesale prices was 63.1 million Euros which shows 9.6% increase comparing to previous year’s same period.

    Human medicinal products market was 60.1 million Euros which shows 9.2% increase.

    Sales to general pharmacies covered 70% and sales to hospital pharmacies 29% of total wholesale turnover. Sales to other institutions, i.e. state and scientific institutions was modest, being 1% of total sales.

    The proportion of prescription sales was 85% which comparing to over the counter sales (14%) and hospital package sales (1%) covered most of the medicinal products market turnover in third quarter 2014.

    Based on ATC classification, antineoplastic and immunomodulating drugs had the biggest turnover (20%), followed by cardiovascular drugs (13%) and alimentary tract and metabolism medicines (12%).

    The Estonian veterinary medicinal products market was 3 million Euros in wholesale prices in the third quarter of 2014. Compared to the third quarter in 2013, the turnover increased 18%.

    Almost 89% of veterinary medicines were sold to the veterinarians or to the agricultural companies represented by a veterinarian, 3,5% to the general pharmacies, 5% to other institutions (generally state- and scientific institutions) and 2% to the veterinary pharmacies.

    The most sold medicines by turnover were anti-infectives (QJ) 36%, immunologicals 25% and antiparasitic products 15%.

    Human medicines were sold to general and hospital pharmacies as well as to other institutions by 30 wholesalers. There were 10 wholesalers who sold veterinary medicinal products.